🇨🇦 R2-combination chemotherapy in Canada

R2-combination chemotherapy (R2-combination chemotherapy) regulatory status in Canada.

Marketing authorisation

R2-combination chemotherapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is R2-combination chemotherapy approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for R2-combination chemotherapy in Canada?

Shandong Provincial Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.